Stockreport

Institutional investors are Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) biggest bettors and were rewarded after last week's US$72m market cap gain [Yahoo! Finance]

Lyell Immunopharma, Inc.  (LYEL) 
PDF A total of 8 investors have a majority stake in the company with 53% ownership Insiders have sold recently AI is about to change healthcare. These 20 stocks are wor [Read more]